Stockscreener 앱 받기
2.61
2.97%
-0.08
시간 외 거래:
2.68
0.07
+2.68%
전일 마감가:
$2.69
열려 있는:
$2.64
하루 거래량:
224.31K
Relative Volume:
0.03
시가총액:
$11.74M
수익:
$6.16M
순이익/손실:
$-14.91M
주가수익비율:
-0.2446
EPS:
-10.6693
순현금흐름:
$-9.39M
1주 성능:
-7.12%
1개월 성능:
-4.40%
6개월 성능:
-7.77%
1년 성능:
-82.48%
1일 변동 폭
$2.61
$2.83
1주일 범위
$2.55
$2.99
52주 변동 폭
$0.693
$16.06
Bioaffinity Technologies Inc Stock (BIAF) Company Profile
명칭
Bioaffinity Technologies Inc
전화
210-698-5334
주소
3300 NACOGDOCHES ROAD, SAN ANTONIO
Compare BIAF vs TMO, DHR, IDXX, A, WAT
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BIAF
Bioaffinity Technologies Inc
|
2.61 | 12.10M | 6.16M | -14.91M | -9.39M | -10.67 |
TMO
Thermo Fisher Scientific Inc
|
524.57 | 195.48B | 44.56B | 6.72B | 6.29B | 17.74 |
DHR
Danaher Corp
|
194.54 | 138.36B | 24.57B | 3.60B | 5.26B | 5.051 |
IDXX
Idexx Laboratories Inc
|
569.01 | 46.31B | 4.30B | 1.06B | 1.04B | 13.08 |
A
Agilent Technologies Inc
|
122.09 | 34.18B | 7.07B | 1.29B | 993.00M | 4.5355 |
WAT
Waters Corp
|
335.23 | 32.95B | 3.17B | 642.63M | 516.49M | 10.77 |
Bioaffinity Technologies Inc 주식(BIAF)의 최신 뉴스
BioAffinity stock surges 113.8% in 3 months: What's driving the rally? - MSN
BioAffinity shares rise as CyPath Lung growth boosts optimism - MSN
bioAffinity Stock Surges 113.8% in 3 Months: What's Driving the Rally? - TradingView — Track All Markets
New Case Study Shows bioAffinity Technologies CyPath Lung Diagnostic Helps Avoid Unnecessary Lung Biopsy - National Today
CyPath® Lung Diagnostic Helps Defer Unnecessary Biopsy - National Today
New Case Study: bioAffinity Technologies’ CyPath® Lung Diagnostic Supports Physician’s Assessment, Prompts Follow-Up Imaging and Defers Unnecessary Biopsy - BioSpace
New Case Study: bioAffinity Technologies’ CyPath® Lung Diagnostic Supports Physician’s Assessment, P - PharmiWeb.com
bioAffinity Highlights CyPath Lung Case Avoiding Unnecessary Biopsy - TipRanks
CyPath Lung case study at bioAffinity (NASDAQ: BIAF) shows biopsy deferred - Stock Titan
UGRO, TURB, ANNA, EEIQ, BIAF: These five stocks outpaced big tech with massive March returns - MSN
Institution Moves: Can bioAffinity Technologies Inc lead its sector in growth2026 Trading Volume Trends & Weekly Watchlist of Top Performers - baoquankhu1.vn
Investment Review: Is bioAffinity Technologies Inc Equity Warrant stock overvalued or fairly priced2026 Buyback Activity & Technical Pattern Based Buy Signals - baoquankhu1.vn
BIAF PE Ratio & Valuation, Is BIAF Overvalued - Intellectia AI
Wall Street Recap: Can bioAffinity Technologies Inc Equity Warrant outperform under higher oil pricesMarket Performance Report & Low Drawdown Investment Ideas - baoquankhu1.vn
Jobs Data: What hedge funds are buying bioAffinity Technologies Inc Equity WarrantWeekly Trading Summary & Risk Adjusted Swing Trade Ideas - baoquankhu1.vn
BIAF Should I Buy - Intellectia AI
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
bioAffinity Technologies’ CyPath® Lung to Be Featured at Cleveland Clinic Annual “Advances in Early - PharmiWeb.com
bioAffinity Technologies’ CyPath® Lung to Be Featured at Cleveland Clinic Annual “Advances in Early Lung Cancer Detection” Symposium April 16 - BioSpace
bioAffinity Showcases CyPath Lung Test at Cleveland Clinic - TipRanks
CyPath Lung spotlight for bioAffinity Technologies (Nasdaq: BIAF) - Stock Titan
Risk Analysis: What are the future prospects of bioAffinity Technologies Inc Equity Warrant2026 Trading Recap & Community Consensus Trade Signals - baoquankhu1.vn
BIAFW Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
BIAF Stock Gains As CyPath Sales Surge 146% In Q1 - stocktwits.com
bioAffinity Technologies, Inc.Common Stock (NQ: BIAF - The Chronicle-Journal
BIAF Stock Price $3.76 | bioAffinity Technologies, Inc. Live Quote - Meyka
bioAffinity reports 146% jump in Q1 lung test sales By Investing.com - Investing.com South Africa
BIAF stock gains as CyPath sales surge 146% in Q1 - MSN
bioAffinity Technologies’ CyPath® Lung Test Sales Surge 146% in Q1 2026, Driven by Growing Adoption for Early Lung Cancer Detection 1 - Minichart
bioAffinity Technologies, Inc. (BIAF) stock price, news, quote and history - Yahoo Finance UK
bioAffinity Reports Surge in CyPath Lung Test Sales - TipRanks
bioAffinity Technologies' CyPath Lung Unit Sales Jump 146% YoY in Q1 2026 - TradingView — Track All Markets
CyPath Lung sales surge 146% at bioAffinity Technologies (NASDAQ: BIAF) - Stock Titan
bioAffinity Tech Surges on Lung Cancer Study Initiative - StocksToTrade
Record Growth in bioAffinity Technologies: CyPath Lung Shines - timothysykes.com
bioAffinity reports 146% jump in Q1 lung test sales - Investing.com
bioAffinity Technologies’ CyPath® Lung Test Unit Sales Surged 146% Year-Over-Year in Q1 2026 - Business Wire
Earnings Beat: What hedge funds are buying bioAffinity Technologies Inc Equity Warrant2026 EndofYear Setup & Fast Exit and Entry Trade Guides - baoquankhu1.vn
BioAffinity Technologies stock cools off after strong Friday rallyhere's why - MSN
bioAffinity Technologies Appoints Three New Medical and Scientific Advisory Board Members - Medical Product Outsourcing
UGRO, TURB, ANNA, EEIQ, BIAF: These Five Stocks Outpaced Big Tech With Massive March Returns - Stocktwits
Can bioAffinity Technologies Inc lead its sector in growth2026 Highlights & Low Risk High Reward Ideas - baoquankhu1.vn
Shorts Report: Is HPPPRC stock a buy or sell2026 Risk Factors & Precise Buy Zone Identification - baoquankhu1.vn
Breakout Watch: Can bioAffinity Technologies Inc Equity Warrant weather a recession2026 Stock Rankings & AI Forecast Swing Trade Picks - baoquankhu1.vn
BIAF Stock Price, Quote & Chart | BIOAFFINITY TECHNOLOGIES INC (NASDAQ:BIAF) - ChartMill
What's going on with bioAffinity Technologies stock Wednesday? - msn.com
bioAffinity Technologies Posts New Investor Presentation Materials - TipRanks
Bioaffinity Technologies Inc (BIAF) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.57%
0.03%
자본화:
|
볼륨(24시간):